Online inquiry

IVTScrip™ mRNA-Human ABHD8, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9672MR)

This product GTTS-WK9672MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methoxy-UTP. It ecodes the ABHD8 protein. This product can be used in FGFR1 High NME5-epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methoxy-UTP
5' Cap Cap 0
Species Human
RefSeq NM_024527.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 79575
UniProt ID Q96I13
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD8, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) (GTTS-WK9672MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK21378MR IVTScrip™ mRNA-Human AKR1D1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AKR1D1
GTTS-WK12320MR IVTScrip™ mRNA-Human AARSD1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AARSD1
GTTS-WK18393MR IVTScrip™ mRNA-Human ALDH16A1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALDH16A1
GTTS-WK22821MR IVTScrip™ mRNA-Human APOBEC3D, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA APOBEC3D
GTTS-WK8023MR IVTScrip™ mRNA-Human ADCY8, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADCY8
GTTS-WK18423MR IVTScrip™ mRNA-Human ALKBH2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALKBH2
GTTS-WK5230MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK15950MR IVTScrip™ mRNA-Human AK4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AK4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW